Peter Gilbert, PhD

Peter Gilbert, PhD

Peter Gilbert is Principal Investigator of the Statistical Data Management Center for the HIV Vaccine Trials Network and the Head of the Biostatistics, Bioinformatics, and Epidemiology Program within the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center. He is also a Member of the Public Health Sciences Division and is a Research Professor in the Department of Biostatistics at the University of Washington. Peter is an active mentor to a number of graduate and post-graduate students from the University of Washington and enjoys accomplishing research objectives with their collaboration.

Peter's current research interests center on the statistical design and analysis of vaccine efficacy trials, with emphasis on assessing immune correlates of vaccine-induced protection including the "sieve analysis" of the pathogen sequences infecting trial volunteers. While being motivated by vaccine efficacy trials for HIV and other pathogens, this research contributes to general areas of statistical methods research including surrogate endpoint assessment, causal inference, survival analysis, and efficient randomized trial design. In collaboration with scientists from the Thai Ministry of Health and the United States Military HIV Research Program, Peter led the statistical design and analysis of an immune correlates study of the RV144 "Thai Trial" (published in 2012), which established a process for correlates discovery that may be useful for other vaccine trial settings. In addition, Peter led the statistical design of a sequential Phase 2b trial design for evaluating vaccine efficacy and immune correlates for multiple HIV vaccine regimens (published in 2011), which is planned for implementation and may be useful for other vaccine trial settings.

Peter holds a B.S. in Mathematics (1992) as well as an M.S. and Ph.D. in Biostatistics (1994 and 1996), all from the University of Washington. He was a post-doctoral fellow and Assistant Professor in the Department of Biostatistics at the Harvard School of Public Health from 1997 to 2011. Peter is a Fellow of the American Statistical Association and his service includes membership on the U.S. FDA’s advisory committee for vaccines and on Data and Safety Monitoring Boards.